Shanghai Zhiyu Software Information Co., Ltd. ("Zhiyu" for short) is an industry-leading medical AI innovation enterprise, focusing on the research and development, sales and service of AI-assisted analysis of medical images and diagnosis and treatment products. Zhiyu is committed to becoming an innovative leader in AI analysis and auxiliary diagnosis and treatment of medical imaging in the field of liver and brain sciences, and to build the first brand of AI in liver and brain professional medical imaging.

Zhiyu's R&D team is led by the world's top medical imaging experts. The core personnel are composed of experts in the medical and imaging fields of Fudan University. More than 80% of the team members have a doctoral degree. Zhiyu owns exclusive world-class medical imaging equipment and massive scientific research-grade medical imaging data. Relying on top medical resources and professional capabilities in the field of liver and brain science at home and abroad, Zhiyu conducts scientific research and clinical cooperation with dozens of top three hospitals. A variety of medical image-assisted analysis and diagnosis and treatment AI software products.

Zhiyu's marketing team is led by management elites with working backgrounds in well-known medical companies around the world and has extremely rich marketing experience. In China, the business covers more than 1,000 tertiary hospitals, and more than 3,000 high-quality channels are submerged to cover the county-level medical market; in the international market, Zhiyu and the American hospital management company HCA, Massachusetts General Hospital, MD Anderson, Mayo, New York Presbyterian Hospital and many well-known institutions have maintained long-term cooperative relationships to provide innovative medical AI products and services for the global medical market.